Free Trial

Clene (CLNNW) Competitors

$0.05
0.00 (0.00%)
(As of 11/1/2024 ET)

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Clene vs.

180 Life Sciences (NASDAQ:ATNFW) and Clene (NASDAQ:CLNNW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Clene N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Clene'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Clene Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Clene
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

180 Life Sciences and Clene both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
CleneN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Clene$442KN/AN/AN/AN/A

Summary

Clene beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$158.40M$5.40B$8.53B
Dividend YieldN/A3.39%5.15%4.14%
P/E RatioN/A348.23112.5515.07
Price / SalesN/A19,806.471,478.8293.55
Price / CashN/A11.3039.8334.04
Price / BookN/A7.514.645.01
Net IncomeN/A-$18.90M$119.13M$225.46M
7 Day PerformanceN/A-0.05%0.78%0.37%
1 Month PerformanceN/A2.54%5.65%3.57%
1 Year PerformanceN/A28.85%36.90%29.42%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.05
flat
N/AN/A$0.00$442,000.000.00100
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-9.1%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.05
+28.6%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
flat
N/AN/A$0.00$65,122.000.0040Positive News
ALVOW
Alvotech
N/A$3.20
+5.3%
N/AN/A$0.00$306.77M0.004Positive News
Gap Down
ALVO
Alvotech
2.0536 of 5 stars
$13.02
+0.3%
$18.00
+38.2%
+51.6%$0.00$93.38M-4.911,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.004Positive News
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$12.54
flat
N/A+19.1%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.07
-64.6%
N/A+119.3%$0.00$35.24M0.0070Gap Down
High Trading Volume
BTMDW
biote
N/A$0.56
flat
N/A-46.8%$0.00$187.23M0.00N/A

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners